IScienceWriter
@isciencewriter
Followers
5K
Following
49
Media
2K
Statuses
19K
International Science Writer (ISW) creating and sharing up-to-the-minute news about #lifescience, #biotech and #pharma industries.
Hitchin, UK
Joined January 2012
NEW OPTURA®PALM® Handheld Contactless Biomass Sensor from Aber Offers Accurate Cell Density Measurement in Seconds Without Sampling. Technology is used across biopharmaceutical, brewing, biofuel industries etc
0
0
0
Check out Asif R. 's DSI - DS InPharmatics, a PLG company Business Development Director's insightful interview with CPHI Online on supply chain issues, data analytics, and their impact on the regulatory landscape in the life sciences industry. Read more: https://t.co/QiVAkKlB1L
0
1
1
Stem Cells May Move to the Front Line against Multiple Sclerosis https://t.co/OOp1pdMuq3 via @DrSuePearson for @GENbio #stemcells #biotech #biopharma
genengnews.com
Researchers maintain that patients with severe multiple sclerosis should be able to receive autologous hematopoietic stem cell transplantation as a first-line therapy.
0
0
1
𝗦𝘂𝗿𝗽𝗿𝗶𝘀𝗲, 𝘀𝘂𝗿𝗽𝗿𝗶𝘀𝗲! "Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (p<0.0001)." ( https://t.co/fm5GMfMGth) And frankly speaking, I doubt that anybody would get ill at all with 25(OH)D levels above 50 ng/mL.
547
4K
12K
Last chance to register for this #webinar on how to scale-up your #cellculture the easy way. #biotech
If one-parameter bioreactor scaling approaches are hurting your efficiency and productivity, you’ll be glad to know there is a better solution. Join this webinar to learn more: https://t.co/ss6iCvkdWS
#cellculture #bioreactor #biotech
0
0
0
Diabetes risk rises after COVID, massive study finds https://t.co/wgd3exmcru
#covid19 #vaccines #diabetes
nature.com
Nature - Even mild SARS-CoV-2 infections can amplify a person’s chance of developing diabetes, especially for those already susceptible to the disease.
0
0
0
20 months after the 40,000 trial subjects were given the Oxford/AZ vaccine, no loss of protection from serious illness has been observed in under 70s who had 2 doses of AstraZeneca almost 2 years ago - Sarah Gilbert. AZ designed as a 2 dose vaccine, not 3, not boost-dependent.
15
63
127
A huge congratulations to Steve Rees for receiving @ELRIG_UK’s Inaugural Lifetime Achievement Award today at #DrugDiscovery2021, in recognition of his significant contribution to the #lifescience sector.
0
5
8
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th https://t.co/ES845J6AQ7
#vaccines
0
0
1
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th https://t.co/ES845J6AQ7
#bioprocessing
0
0
0
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th https://t.co/ES845J6AQ7
#biopharma
0
1
1
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th https://t.co/ES845J6AQ7
#pharma
0
0
0
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th https://t.co/ES845J6AQ7
#bioreactor
0
0
0
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th https://t.co/ES845J6AQ7
#biotech
0
0
0
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th https://t.co/ES845J6AQ7
#biotech
0
0
0
Are you finding scaling-up and scaling-down between bioreactors a challenge? Then register for our scaling webinar on September 14 to gain insights from our experts into simplifying and de-risking the process. https://t.co/SQ280TSIVu
0
1
0
Our vaccine experts reflect on the lessons learned following the industry’s yearlong response to the COVID-19 pandemic. Watch the video to hear Amélie Boulais and Piergiuseppe Nestola answer important questions about current and future vaccine development. https://t.co/G8DPgWBSqH
1
2
4